Patent · US Active

5-alkynyl-pyrimidines

US8916548B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Tobias Wunberg · Mödling, AT
Ralph Brueckner · Wien, AT
Dirk Kessler · Wien, AT
Oliver Kraemer · Wien, AT
Darryl McConnell · Wien, AT
Siegfried Schneider · Wien, AT
Lars Van Der Veen · Wien, AT

Key dates

Filing date	Jul 28, 2009
Grant date	Dec 23, 2014
Priority date	—
Expiry date	Nov 15, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.